CVD

Explore the complexities of CVD research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against CVD with flcube.com.

EMA's CHMP Backs Indication Extension for Johnson & Johnson's TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma
CompanyDrug

EMA’s CHMP Backs Indication Extension for Johnson & Johnson’s TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma

Johnson & Johnson (J&J; NYSE: JNJ) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of an indication…

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

FDA Approves Roche's Enspryng for Thyroid Eye Disease – Satralizumab Becomes First and Only At‑Home Subcutaneous TED Treatment

FDA Approves Roche’s Enspryng for Thyroid Eye Disease – Satralizumab Becomes First and Only At‑Home Subcutaneous TED Treatment

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Mindray to Acquire 21.12% Stake in APT Medical for RMB 6.652 Billion

CompanyDrug

Apeloa Pharmaceutical Halts Phase III Trial of Salfaprodil for Acute Ischemic Stroke

CompanyMedical Device

Lepu Medical Technology Gains NMPA Approval for Innovative Coronary Device

CompanyDeals

Lee’s Pharmaceutical to Develop Windtree’s Cardiovascular Drugs in Greater China

CompanyMedical Device

Abbott Initiates Clinical Study for Volt PFA System in Australia for Cardiac Arrhythmias

CompanyDrug

Tasly Pharmaceuticals Gets NMPA Go-Ahead for Clinical Trial of Stem Cell Therapy in Heart Failure

CompanyDeals

China Grand Pharma to Acquire 63% Stake in Duoputai for RMB 442 Million

CompanyDeals

Cytokinetics Attracts Big Pharma Interest Amid Aficamten’s Phase III Success

Show More